CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 70 enrolled
Drug / intervention
Hypnoanalgésiabehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05413174
NCT05413174N/ACompleted
CompareCT.gov

Contribution of Hypnosis in Guided Hepatic Biopsy

Assistance Publique - Hôpitaux de Paris·interventional·Posted Jun 9, 2022·Updated Mar 4, 2026

In Brief

A clinical study evaluating Hypnoanalgésia for Ultrasound-guided Hepatic Biopsy. Completed, enrolled 70 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the contribution of hypnosis on the level of pain felt by the patient during ultrasound-guided hepatic biopsy, by comparing an intervention group (hypnosis) to a control group (routine and benevolent care). Single-center randomized controlled trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUltrasound-guided Hepatic Biopsy
CountriesFrance
CollaboratorsURC-CIC Paris Descartes Necker Cochin

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 9, 2022
Enrollment StartSep 29, 2022
Primary CompletionJun 1, 2023
Study CompletionJun 2, 2023
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 4.1 years ago

Interventions

Hypnoanalgésiabehavioral

Use of Ericksonienne hypnosis in the medical field, aiming to dissociate the patient from the intervention in order to modify his or her perception of pain and limit anxiety. Ericksonienne hypnosis will use during ultrasound-guided biopsy in radiology ward.